Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

LA JOLLA PHARMACEUTICAL CO (LJPC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/01/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/29/2022 SC 13D/A GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in La Jolla Pharmaceutical Co.
08/29/2022 SC 13D GARDNER LEWIS ASSET MANAGEMENT L P reports a 6% stake in La Jolla Pharmaceutical Co.
08/24/2022 4 Rosen Robert (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 18,000 options to buy @ $8.52, valued at $153.4k
Disposed/sold 10,000 options to buy @ $19.69, valued at $196.9k
Disposed/sold 10,000 options to buy @ $28.24, valued at $282.4k
Disposed/sold 10,000 options to buy @ $19.19, valued at $191.9k
Disposed/sold 10,000 options to buy @ $28.1, valued at $281k
Disposed/sold 12,000 options to buy @ $5.99, valued at $71.9k
Disposed/sold 12,000 options to buy @ $3.93, valued at $47.2k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
08/24/2022 4 RAMSAY DAVID A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 100,000 shares @ $6.23, valued at $623k
Disposed/sold 18,000 options to buy @ $8.43, valued at $151.7k
Disposed/sold 12,000 options to buy @ $3.93, valued at $47.2k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
08/24/2022 4 TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Unknown transaction of 9,607,934 shares @ $6.23, valued at $59.9M
Disposed/sold 18,000 options to buy @ $9.2, valued at $165.6k
Disposed/sold 10,000 options to buy @ $19.69, valued at $196.9k
Disposed/sold 10,000 options to buy @ $28.24, valued at $282.4k
Disposed/sold 10,000 options to buy @ $19.19, valued at $191.9k
Disposed/sold 10,000 options to buy @ $28.1, valued at $281k
Disposed/sold 12,000 options to buy @ $5.99, valued at $71.9k
Disposed/sold 12,000 options to buy @ $3.93, valued at $47.2k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
Unknown transaction of 3,519 options to buy @ $0
08/24/2022 4 Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 11,969 shares @ $6.23, valued at $74.6k
Disposed/sold 400,000 options to buy @ $3.89, valued at $1.6M
Disposed/sold 278,350 options to buy @ $4.53, valued at $1.3M
Disposed/sold 322 options to buy @ $4.18, valued at $1.3k
Disposed/sold 304 options to buy @ $4.44, valued at $1.3k
Disposed/sold 358 options to buy @ $3.76, valued at $1.3k
Disposed/sold 314 options to buy @ $4.3, valued at $1.4k
Disposed/sold 275 options to buy @ $4.9, valued at $1.3k
Disposed/sold 315 options to buy @ $4.28, valued at $1.3k
Disposed/sold 374 options to buy @ $3.61, valued at $1.4k
Disposed/sold 338 options to buy @ $3.98, valued at $1.3k
08/24/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 1,675 options to buy @ $4.63, valued at $7.8k
Disposed/sold 169 options to buy @ $4.46, valued at $753.7
Disposed/sold 185 options to buy @ $4.09, valued at $756.7
Disposed/sold 177 options to buy @ $4.27, valued at $755.8
Disposed/sold 173 options to buy @ $4.37, valued at $756
Disposed/sold 185 options to buy @ $4.08, valued at $754.8
Disposed/sold 236 options to buy @ $3.2, valued at $755.2
Disposed/sold 236 options to buy @ $3.19, valued at $752.8
Unknown transaction of 3,519 options to buy @ $0
08/24/2022 4 Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 500 shares @ $6.23, valued at $3.1k
Disposed/sold 13,500 options to buy @ $6, valued at $81k
Disposed/sold 13,000 options to buy @ $10.84, valued at $140.9k
Disposed/sold 10,000 options to buy @ $19.69, valued at $196.9k
Disposed/sold 10,000 options to buy @ $28.24, valued at $282.4k
Disposed/sold 10,000 options to buy @ $19.19, valued at $191.9k
Disposed/sold 10,000 options to buy @ $28.1, valued at $281k
Disposed/sold 12,000 options to buy @ $5.99, valued at $71.9k
Disposed/sold 12,000 options to buy @ $3.93, valued at $47.2k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
08/24/2022 4 Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 12,000 shares @ $6.23, valued at $74.8k
Disposed/sold 18,000 options to buy @ $6, valued at $108k
Disposed/sold 19,000 options to buy @ $10.84, valued at $206k
Disposed/sold 10,000 options to buy @ $19.69, valued at $196.9k
Disposed/sold 10,000 options to buy @ $28.24, valued at $282.4k
Disposed/sold 10,000 options to buy @ $19.19, valued at $191.9k
Disposed/sold 10,000 options to buy @ $28.1, valued at $281k
Disposed/sold 12,000 options to buy @ $5.99, valued at $71.9k
Disposed/sold 30,000 options to buy @ $5.25, valued at $157.5k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
08/24/2022 4 Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Disposed/sold 10,186 shares @ $6.23, valued at $63.5k
Unknown transaction of 9,607,934 shares @ $6.23, valued at $59.9M
Disposed/sold 100,000 options to buy @ $4.55, valued at $455k
Disposed/sold 169 options to buy @ $3.91, valued at $660.8
Disposed/sold 196 options to buy @ $3.4, valued at $666.4
Disposed/sold 141 options to buy @ $4.68, valued at $659.9
Disposed/sold 134 options to buy @ $4.97, valued at $666
Disposed/sold 52,191 options to buy @ $4.53, valued at $236.4k
Disposed/sold 147 options to buy @ $4.5, valued at $661.5
Disposed/sold 1,648 options to buy @ $3.88, valued at $6.4k
Disposed/sold 136 options to buy @ $5.35, valued at $727.6
08/24/2022 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Unknown transaction of 9,607,934 shares @ $6.23, valued at $59.9M
Unknown transaction of 3,519 options to buy @ $0
08/24/2022 SC 13D/A TANG CAPITAL PARTNERS LP reports a 0% stake in La Jolla Pharmaceutical Company
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/22/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/22/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of La Jolla Pharmaceutical Company",
"Amended and Restated Bylaws of La Jolla Pharmaceutical Company"
08/22/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/22/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/16/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/15/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/25/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
07/25/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
07/12/2022 4 Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Exercised 12,000 options to buy @ $3.93, valued at $47.2k
07/12/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
07/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/11/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
07/11/2022 425 Form 425 - Prospectuses and communications, business combinations:
07/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy